The Asia Pacific Opioids Market would witness market growth of 3.5% CAGR during the forecast period (2021-2027).
Synthetic opioids (e.g., morphine and codeine) impact the same regions of the brain as natural opioids (e.g., morphine and codeine) to provide analgesic (pain-relieving) effects. Natural opioids, on the other hand, are naturally occurring compounds derived from the seed pods of specific poppy types. Fentanyl and methadone, for example, are synthetic opioids that have been approved for medicinal usage. In the late 1970s and 1980s, illicitly manufactured synthetic opioids structurally linked to the Schedule II opioid painkiller fentanyl were trafficked and misused on the West Coast. DEA controlled alphamethylfentanyl, 3-methylthiofentanyl, acetyl-alphamethylfentanyl, beta-hydroxy-3-methylfentanyl, alpha-methylthiofentanyl, thiofentanyl, betahydroxyfentanyl, para-fluorofentanyl, and 3-methylfentanyl in the 1980s.
Chronic pain is long-term pain that lasts longer than the normal recovery period or comes in conjunction with a chronic health condition like arthritis. Chronic pain can be intermittent or persistent. It may cause people to be unable to work, eat well, engage in physical activity, or simply enjoy life.
China is the world's second-largest pharmaceutical market, and it's flourishing due to two major factors: large-scale capital investment and strong increases in productivity. These two variables suggest that the country will be a desirable investment destination as well as a source of huge local savings. The country has been transitioning from a low-income to a more market-oriented economy since the 1970s. Due to its large-scale manufacturing capacity and high opioid consumption, China is witnessing a surge in the regional market. In recent years, both large and small pharmaceutical companies have made significant investments in research and development. Since most medications in the pipeline are nearing completion and will be ready by the end of the decade, opioid demand is expected to rise. In underdeveloped countries, it is easier to find patients for clinical studies.
The China market dominated the Asia Pacific Opioids Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $421.2 million by 2027. The Japan market is poised to grow at a CAGR of 2.9% during (2021 - 2027). Additionally, The India market would witness a CAGR of 4.3% during (2021 - 2027).
Based on Application, the market is segmented into Pain Management, Cough Treatment and Diarrhea Treatment. Based on Product Type, the market is segmented into Methadone, Oxycodone, Hydrocodone, Fentanyl, Codeine, Morphine and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Opioids Market is Projected to reach USD 5.4 Billion by 2027, at a CAGR of 3.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Endo International PLC, Mallinckrodt PLC, Sanofi S.A., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., and Purdue Pharma L.P.
By Application
By Product Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
